Intimal Sarcoma with MDM2/CDK4 Amplification and p16 Overexpression: A Review of Histological Features in Primary Tumor and Xenograft, with Immunophenotype and Molecular Profiling
暂无分享,去创建一个
S. Navarro | J. López-Guerrero | I. Machado | A. Ferrández | F. Giner | E. Mayordomo-Aranda | L. Rubio-Martínez | A. Llombart-Bosch | Reyes Claramunt-Alonso
[1] B. Rah,et al. Telomere Attrition With Concomitant hTERT Overexpression Involved in the Progression of Gastric Cancer May Have Prognostic and Clinical Implications in High-Risk Population Group From North India , 2022, Frontiers in Oncology.
[2] K. Tsuchihashi,et al. Myxoid type and non-myxoid type of intimal sarcoma in large vessels and heart: review of histological and genetic profiles of 20 cases , 2022, Virchows Archiv.
[3] David C. Jones,et al. Intimal sarcomas and undifferentiated cardiac sarcomas carry mutually exclusive MDM2, MDM4, and CDK6 amplifications and share a common DNA methylation signature , 2021, Modern Pathology.
[4] R. Sciot. MDM2 Amplified Sarcomas: A Literature Review , 2021, Diagnostics.
[5] M. Sbaraglia. Intimal Sarcoma , 2020, Encyclopedia of Pathology.
[6] A. Llombart‐Bosch,et al. Solitary fibrous tumor: a case series identifying pathological adverse factors—implications for risk stratification and classification , 2019, Virchows Archiv.
[7] J. Roszik,et al. Unique Aberrations in Intimal Sarcoma Identified by Next-Generation Sequencing as Potential Therapy Targets , 2019, Cancers.
[8] E. Rasmussen,et al. Phase 1b study of the MDM2 inhibitor AMG 232 with or without trametinib in relapsed/refractory acute myeloid leukemia. , 2019, Blood advances.
[9] Xin Li,et al. A novel inhibitor of MDM2 oncogene blocks metastasis of hepatocellular carcinoma and overcomes chemoresistance , 2019, Genes & diseases.
[10] Narasimhan P. Agaram,et al. GLI1-amplifications expand the spectrum of soft tissue neoplasms defined by GLI1 gene fusions , 2019, Modern Pathology.
[11] Robin L. Jones,et al. Systemic treatments in MDM2 positive intimal sarcoma: A multicentre experience with anthracycline, gemcitabine, and pazopanib within the World Sarcoma Network , 2019, Cancer.
[12] M. Warmuth,et al. H3B-8800, an orally available small-molecule splicing modulator, induces lethality in spliceosome-mutant cancers , 2018, Nature Medicine.
[13] Moriah H Nissan,et al. OncoKB: A Precision Oncology Knowledge Base. , 2017, JCO precision oncology.
[14] S. Ishikawa,et al. Cardiac intimal sarcoma with PDGFRβ mutation and co-amplification of PDGFRα and MDM2: an autopsy case analyzed by whole-exome sequencing , 2017, Virchows Archiv.
[15] AACR Project GENIE: Powering Precision Medicine through an International Consortium. , 2017, Cancer discovery.
[16] F. Collin,et al. Intimal Sarcoma Is the Most Frequent Primary Cardiac Sarcoma: Clinicopathologic and Molecular Retrospective Analysis of 100 Primary Cardiac Sarcomas , 2014, The American journal of surgical pathology.
[17] P. Dartevelle,et al. Retrospective institutional study of 31 patients treated for pulmonary artery sarcoma. , 2013, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[18] C. Fletcher,et al. WHO classification of tumours of soft tissue and bone , 2013 .
[19] Marc Ladanyi,et al. Advances in sarcoma genomics and new therapeutic targets , 2011, Nature Reviews Cancer.
[20] P. Marynen,et al. Coactivated platelet-derived growth factor receptor {alpha} and epidermal growth factor receptor are potential therapeutic targets in intimal sarcoma. , 2010, Cancer research.
[21] Derek Y. Chiang,et al. Subtype-specific genomic alterations define new targets for soft tissue sarcoma therapy , 2010, Nature Genetics.
[22] C. Moran,et al. Management of primary pulmonary artery sarcomas. , 2009, The Annals of thoracic surgery.
[23] S. Blackmon,et al. Management of primary cardiac sarcomas , 2008, Expert review of cardiovascular therapy.
[24] U. Pastorino,et al. Analysis of potential receptor tyrosine kinase targets in intimal and mural sarcomas , 2007, The Journal of pathology.
[25] S. Knuutila,et al. Undifferentiated Intimal Sarcoma of Large Systemic Blood Vessels: Report of 14 Cases With Immunohistochemical Profile and Review of the Literature , 2005, The American journal of surgical pathology.
[26] Dr. Moritz Mandelstamm. Über primäre Neubildungen des Herzens , 1923, Virchows Archiv für pathologische Anatomie und Physiologie und für klinische Medizin.
[27] Kuang-Tai Kuo,et al. Pulmonary Artery Sarcoma–A Case Report and Review of the Literature , 2004 .
[28] E. Speel,et al. Gains of 12q13–14 and overexpression of mdm2 are frequent findings in intimal sarcomas of the pulmonary artery , 2000, Virchows Archiv.
[29] T. Mentzel,et al. Intravascular (”intimal”) epithelioid angiosarcoma: clinicopathological and immunohistochemical analysis of three cases , 1999, Virchows Archiv.
[30] P. Schlag,et al. GLI gene expression in bone and soft tissue sarcomas of adult patients correlates with tumor grade. , 1999, Cancer research.
[31] J. Goldblum,et al. Epithelioid angiosarcoma of the pulmonary artery. , 1995, Human pathology.
[32] Renu Virmani,et al. Sarcomas of the great vessels. A clinicopathologic study , 1993, Cancer.
[33] Y. Nakanuma,et al. PRIMARY PULMONARY ARTERY SARCOMA. Report of Two Autopsy Cases Studied by Immunohistochemistry and Electron Microscopy, and Review of 110 Cases Reported in the Literature , 1988, Acta pathologica japonica.